H.R. 842

Status: Reported

Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act

Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act

Sponsored by Jodey C. Arrington (Republican-TX-19)

Topics

Cosponsors

338

Actions

7

Roll calls

0

Amendments

0

Related bills

4

Actions

Oct 3, 2025 · Library of Congress

Reported (Amended) by the Committee on Ways and Means. H. Rept. 119-333, Part I.

Oct 3, 2025 · House floor actions

Reported (Amended) by the Committee on Ways and Means. H. Rept. 119-333, Part I.

Sep 17, 2025 · House committee actions

Committee Consideration and Mark-up Session Held

Sep 17, 2025 · House committee actions

Ordered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 43 - 0.

Jan 31, 2025 · Library of Congress

Introduced in House

Jan 31, 2025 · Library of Congress

Introduced in House

Jan 31, 2025 · House floor actions

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Latest activity

July 2026

Lobbying reported · America's Health Insurance Plans (ahip) · Jul 20

America's Health Insurance Plans (ahip) reported 2nd Quarter (Apr 1 - June 30) lobbying for America's Health Insurance Plans (ahip) — $3,010,000

BillsH.R. 1 H.R. 247 H.R. 379 H.R. 584 H.R. 608 H.R. 610 H.R. 842 H.R. 935 H.R. 950 H.R. 957 H.R. 1096 H.R. 1117 H.R. 1157 H.R. 1162 H.R. 1397 H.R. 1403 H.R. 1523 H.R. 1614 H.R. 1627 H.R. 1775 H.R. 1776 H.R. 1805 H.R. 1867 H.R. 1899 H.R. 1924 H.R. 2013 H.R. 2045 H.R. 2049 H.R. 2079 H.R. 2199 H.R. 2309 H.R. 2433 H.R. 2450 H.R. 2528 H.R. 2533 H.R. 2553 H.R. 2554 H.R. 2571 H.R. 2586 H.R. 2610 H.R. 2636 H.R. 2741 H.R. 3000 H.R. 3023 H.R. 3069 H.R. 3415 H.R. 3493 H.R. 3527 H.R. 3546 H.R. 3701 H.R. 3789 H.R. 3808 H.R. 4093 H.R. 4206 H.R. 4231 H.R. 4313 H.R. 4317 H.R. 4406 H.R. 4559 H.R. 4605 H.R. 4623 H.R. 4641 H.R. 4710 H.R. 5081 H.R. 5145 H.R. 5243 H.R. 5281 H.R. 5371 H.R. 5509 H.R. 5526 H.R. 5582 H.R. 5584 H.R. 6010 H.R. 6232 H.R. 6248 H.R. 6255 H.R. 6361 H.R. 6703 H.R. 6951 H.R. 6974 H.R. 7023 H.R. 7064 H.R. 7164 H.R. 7189 H.R. 7409 H.R. 7537 H.R. 7727 H.R. 7778 H.R. 7787 H.R. 7790 H.R. 7803 H.R. 7837 H.R. 7871 H.R. 8270 H.R. 8375 H.R. 8377 H.R. 8684 H.R. 8779 H.R. 8875 H.R. 9393 H.R. 9504 S. 339 S. 483 S. 526 S. 529 S. 652 S. 717 S. 729 S. 752 S. 864 S. 882 S. 891 S. 931 S. 939 S. 976 S. 1040 S. 1041 S. 1056 S. 1082 S. 1096 S. 1227 S. 1261 S. 1414 S. 1637 S. 1753 S. 1816 S. 1818 S. 1847 S. 1954 S. 1973 S. 2237 S. 2289 S. 2345 S. 2355 S. 2356 S. 2497 S. 2556 S. 2620 S. 2658 S. 2709 S. 2903 S. 3014 S. 3599 S. 3642 S. 3690 S. 3727 S. 3729 S. 3750 S. 3751 S. 3762 S. 3822 S. 3829 S. 3834 S. 3848 S. 3886 S. 3990 S. 4189 S. 4332 S. 4355 S. 4384 S. 4509 S. 4512

Lobbying reported · Ballard Spahr · Jul 20

Ballard Spahr reported 2nd Quarter (Apr 1 - June 30) lobbying for Grail — $20,000

BillsH.R. 842 S. 339

Lobbying reported · Boehringer Ingelheim USA Corporation, Formerly Reported As Boehringer Ingelheim Pharmaceuticals · Jul 20

Boehringer Ingelheim USA Corporation, Formerly Reported As Boehringer Ingelheim Pharmaceuticals reported 2nd Quarter (Apr 1 - June 30) lobbying for Boehringer Ingelheim USA — $710,000

BillsH.R. 842 H.R. 1492 H.R. 7567 S. 339 S. 832

Lobbying reported · American Association of Nurse Practitioners · Jul 20

American Association of Nurse Practitioners reported 2nd Quarter (Apr 1 - June 30) lobbying for American Association of Nurse Practitioners — $400,000

Lobbying reported · Miller Strategies · Jul 20

Miller Strategies reported 2nd Quarter (Apr 1 - June 30) lobbying for Grail — $60,000

BillsH.R. 842 S. 339

Lobbying reported · John Hancock Life Insurance Company (u.s.a.) · Jul 20

John Hancock Life Insurance Company (u.s.a.) reported 2nd Quarter (Apr 1 - June 30) lobbying for John Hancock Life Insurance Company (u.s.a.) — $400,000

BillsH.R. 842 H.R. 2547 H.R. 3383 S. 1335

Lobbying reported · Grail · Jul 20

Grail reported 2nd Quarter (Apr 1 - June 30) lobbying for Grail — $790,000

BillsH.R. 842 S. 339

Lobbying reported · B Hall Strategies · Jul 19

B Hall Strategies reported 2nd Quarter (Apr 1 - June 30) lobbying for Tiber Creek Health Strategies, Inc. On Behalf Of Grail — $30,000

Lobbying reported · Bluecross Blueshield Of Tennessee · Jul 18

Bluecross Blueshield Of Tennessee reported 2nd Quarter (Apr 1 - June 30) lobbying for Bluecross Blueshield Of Tennessee — $140,000

BillsH.R. 842 H.R. 2079 H.R. 3514 H.R. 4570 H.R. 4710 H.R. 6248 H.R. 8684 H.R. 8871 H.R. 9393 S. 1040 S. 1096 S. 2355 S. 3014 S. 3762 S. 4027

Lobbying reported · Tiber Creek Health Strategies, Inc. (on Behalf Of Eli Lilly And Company) · Jul 18

Tiber Creek Health Strategies, Inc. (on Behalf Of Eli Lilly And Company) reported 2nd Quarter (Apr 1 - June 30) lobbying for Grail — $50,000

BillsH.R. 842 S. 339

You’re all caught up.